Your browser doesn't support javascript.
loading
Evaluation of S-RBD and high specificity ACE-2-binding antibodies on SARS-CoV-2 patients after six months from infection.
Tomassetti, Flaminia; Nuccetelli, Marzia; Sarubbi, Serena; Gisone, Francesca; Ciotti, Marco; Spinazzola, Francesco; Ricotta, Cristina; Cagnoli, Monica; Borgatti, Monica; Iannetta, Marco; Andreoni, Massimo; Calugi, Graziella; Pieri, Massimo; Bernardini, Sergio.
Afiliação
  • Tomassetti F; Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy; Lifebrain srl, Viale Roma 190/A, Guidonia Montecelio, Rome, Italy.
  • Nuccetelli M; Department of Laboratory Medicine, Tor Vergata University Hospital, Rome, Italy.
  • Sarubbi S; Department of Experimental Medicine, University of Tor Vergata, Rome, Italy.
  • Gisone F; Department of Experimental Medicine, University of Tor Vergata, Rome, Italy.
  • Ciotti M; Department of Laboratory Medicine, Virology Unit, Tor Vergata University Hospital, Rome, Italy.
  • Spinazzola F; Lifebrain srl, Viale Roma 190/A, Guidonia Montecelio, Rome, Italy.
  • Ricotta C; Lifebrain Liguria, Via G.B. Monti, 109 R, Genoa, Italy.
  • Cagnoli M; Lifebrain Liguria, Via G.B. Monti, 109 R, Genoa, Italy.
  • Borgatti M; Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy.
  • Iannetta M; Department of Functional Area of Integrated Care Services, Infectious Diseases Clinic, Tor Vergata University Hospital, Rome, Italy; Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
  • Andreoni M; Department of Functional Area of Integrated Care Services, Infectious Diseases Clinic, Tor Vergata University Hospital, Rome, Italy; Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
  • Calugi G; Lifebrain srl, Viale Roma 190/A, Guidonia Montecelio, Rome, Italy.
  • Pieri M; Lifebrain srl, Viale Roma 190/A, Guidonia Montecelio, Rome, Italy; Department of Laboratory Medicine, Tor Vergata University Hospital, Rome, Italy; Department of Experimental Medicine, University of Tor Vergata, Rome, Italy. Electronic address: massimo.pieri@uniroma2.it.
  • Bernardini S; Department of Laboratory Medicine, Tor Vergata University Hospital, Rome, Italy; Department of Experimental Medicine, University of Tor Vergata, Rome, Italy.
Int Immunopharmacol ; 99: 108013, 2021 Oct.
Article em En | MEDLINE | ID: mdl-34339963

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Enzima de Conversão de Angiotensina 2 / COVID-19 / Anticorpos Antivirais Tipo de estudo: Diagnostic_studies / Observational_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Int Immunopharmacol Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Enzima de Conversão de Angiotensina 2 / COVID-19 / Anticorpos Antivirais Tipo de estudo: Diagnostic_studies / Observational_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Int Immunopharmacol Ano de publicação: 2021 Tipo de documento: Article